Pricing

Targanta Therapeutics Corp (TARG)

followers ·
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
222 THIRD AVENUE CAMBRIDGE, MA 02142

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Targanta Therapeutics Corporation, a biopharmaceutical company, focuses on the development and commercialization of antibiotics for infections treated or acquired in hospitals and other institutional settings. It is developing Oritavancin, a novel intravenous antibiotic, for the treatment of gram-positive bacterial infections, including complicated skin and skin structure infections, and bacteremia, an infection caused by bacteria in the bloodstream.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available